Overview
Neurexo Biosciences develops small-molecule therapeutics targeting synaptic plasticity pathways to treat treatment-resistant depression and post-traumatic stress disorder.
More in Neuropharmaceuticals
Latest industry news
Wearable Brain-Computer Interfaces Are Closer to Mainstream Than You Think
2026-11-08 · Industry
Dual-Branch Deep Learning Network Sets New Bar for Motor Imagery BCI Decoding
2026-11-07 · Research
Nurosym Launches Wearable VNS Device as Neuromodulation Interest Reaches New Heights
2026-11-06 · Product
Brain-Computer Interface Project Aims to Build a Google Map of the Human Brain
2026-11-05 · Research
Company details
Category
💊 Neuropharmaceuticals
Location
San Diego, CA
Funding
Series A — $42M
Website
neurexobio.comListed
2026-10-19
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →